Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Last week, MarketAxess Holdings Inc. (MKTX - Snapshot Report) announced the approval of a special cash dividend of $1.30 per share by its board of directors. This implies a dividend yield of 3.98%, based on the company’s closing share price of $32.69 as of Dec 10, 2012.
The special dividend will be paid on Dec 27, 2012 to shareholders of record as of Dec 14, 2012. MarketAxess expects a cash outlay of about $50 million for the dividend payment, considering the number of shares outstanding at present.
The company will use its cash-in-hand to pay the dividend. This will substantially reduce MarketAxess’ cash and cash equivalents, which stood at $150.1 million as of Sep 30, 2012. However, the company generated operating cash flow of $53.3 million during the first nine months of 2012, which is adequate to cover the expenditure for the special dividend.
The strong cash flows generated by MarketAxess have resulted in a sturdy balance sheet and abundant free cash. Consequently, the company strives to return its excess capital to shareholders regularly through dividends and share repurchases, apart from investing in new business.
In addition to this special dividend, MarketAxess paid a regular quarterly dividend of 11 cents per share last month, to shareholders of record as of Nov 12, 2012. Moreover, as a part of its capital management policy, the company spent $26.6 million for repurchasing 870,139 shares between October 2011 and September 2012 under a $35 million share repurchase program, authorized in October 2011.
MarketAxess carries a Zacks #2 Rank (Buy). We maintain a long-term ‘Neutral’ recommendation on the stock. Peer Deutsche Boerse AG (DBOEY) also carries a Zacks #2 Rank.
Get the full on DBOEY - FREE
Get the full Snapshot Report on MKTX - FREE